New drug is potential breakthrough in leukemia research

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

(CNN/10TV News)– It’s almost amazing and hopeful as it sounds: a pill that stops leukemia in its tracks? 

Doctors at Ohio State University say they have witnessed a leukemia breakthrough!

Patient Dennis Hickey admits he should be dead.

“I’m here, and I shouldn’t be,” Hickey said.

Thanks to these grey pills, Hickey has defied the odds associated with stage-four terminal leukemia.

“I should have passed away 10 years ago,” he said.

Hickey was part of clinical trial at Ohio State, using the drug ibrutinib.

According to Dr. John Byrd, of the 900 patients in the trial, everyone has gone into remission.

“In most patients, there leukemia stays away,” said Dr. Byrd.

He says the drug works like a light switch, turning off the power to the cancer cell and it stays off.

“It causes the cells to regress and stop growing in the patient,” said the doctor.

For Hickey, the opportunity to grow old and see his 11 grandchild is something he says he never imagined, considering doctors gave him six months to live.

“I feel better than I did 10 years ago,” Hickey said.

Years he says he may never had, if not for these grey pills.